135 related articles for article (PubMed ID: 10456368)
1. Metabolic and functional effects of low-potassium cardioplegic solutions for long-term heart preservation.
Desrois M; Sciaky M; Lan C; Cozzone PJ; Bernard M
MAGMA; 1999 May; 8(2):77-82. PubMed ID: 10456368
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of a low K+ cardioplegic solution on myocardial Na,K-ATPase activity.
Bernard M; Robert K; Caus T; Desrois M; Paganelli F; Cozzone PJ; Maixent JM
Cell Mol Biol (Noisy-le-grand); 2004 Nov; 50(7):841-4. PubMed ID: 15672468
[TBL] [Abstract][Full Text] [Related]
3. L-arginine during long-term ischemia: effects on cardiac function, energetic metabolism and endothelial damage.
Desrois M; Sciaky M; Lan C; Cozzone PJ; Bernard M
J Heart Lung Transplant; 2000 Apr; 19(4):367-76. PubMed ID: 10775818
[TBL] [Abstract][Full Text] [Related]
4. Optimized cardiac graft preservation: a comparative experimental study using P-31 magnetic resonance spectroscopy and biochemical analyses.
Bernard M; Caus T; Sciaky M; Lan C; Cozzone PJ
J Heart Lung Transplant; 1999 Jun; 18(6):572-81. PubMed ID: 10395355
[TBL] [Abstract][Full Text] [Related]
5. The role of isocolloidoosmotic synthetic colloid addition to St. Thomas Hospital cardioplegic solution for cardioprotection in isolated perfused rat hearts.
Süzer O; Diri E; Konukoğlu D; Ozüner Z
Pharmacol Res; 1997 Jul; 36(1):9-15. PubMed ID: 9368909
[TBL] [Abstract][Full Text] [Related]
6. Eighteen-hour preservation of rat hearts with hexanol and pyruvate cardioplegia.
Kojima S; Wu ST; Wikman-Coffelt J; Parmley WW
J Am Coll Cardiol; 1993 Apr; 21(5):1238-44. PubMed ID: 8459083
[TBL] [Abstract][Full Text] [Related]
7. Long-term preservation of the heart: the effect of infusion pressure during continuous hypothermic cardioplegia.
Chambers DJ; Takahashi A; Hearse DJ
J Heart Lung Transplant; 1992; 11(4 Pt 1):665-75. PubMed ID: 1498129
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and morphological changes in isolated rabbit hearts after prolonged hypothermic ischaemia: comparison of two cardioplegic solutions.
Poltronieri R; Cevese A; Bregu R; Motta A; Zancanaro C; Bernocchi P
Physiol Res; 1995; 44(3):157-64. PubMed ID: 8869272
[TBL] [Abstract][Full Text] [Related]
9. Long-term myocardial preservation: beneficial and additive effects of polarized arrest (Na+-channel blockade), Na+/H+-exchange inhibition, and Na+/K+/2Cl- -cotransport inhibition combined with calcium desensitization.
Snabaitis AK; Chambers D
Transplantation; 1999 Nov; 68(10):1444-53. PubMed ID: 10589937
[TBL] [Abstract][Full Text] [Related]
10. The effectiveness of University of Wisconsin solution on prolonged myocardial protection as assessed by phosphorus 31-nuclear magnetic resonance spectroscopy and functional recovery.
Karck M; Vivi A; Tassini M; Schwalb H; Askenasy N; Navon G; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1356-64. PubMed ID: 1434717
[TBL] [Abstract][Full Text] [Related]
11. Continuous warm versus intermittent cold cardioplegic infusion: a comparison of energy metabolism, sodium-potassium adenosine triphosphatase activity, and postischemic functional recovery in the blood-perfused rat heart.
Qiu Y; Galiñanes M; Haddock PS; Hcarse DJ
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):797-805. PubMed ID: 8800170
[TBL] [Abstract][Full Text] [Related]
12. Preservation of amino acids during long term ischemia and subsequent reflow with supplementation of L-arginine, the nitric oxide precursor, in the rat heart.
Desrois M; Sciaky M; Lan C; Cozzone PJ; Bernard M
Amino Acids; 2003; 24(1-2):141-8. PubMed ID: 12624746
[TBL] [Abstract][Full Text] [Related]
13. Enflurane and isoflurane, but not halothane, protect against myocardial reperfusion injury after cardioplegic arrest with HTK solution in the isolated rat heart.
Preckel B; Schlack W; Thämer V
Anesth Analg; 1998 Dec; 87(6):1221-7. PubMed ID: 9842801
[TBL] [Abstract][Full Text] [Related]
14. Effect of sodium aspartate on the recovery of the rat heart from long-term hypothermic storage.
Galiñanes M; Chambers DJ; Hearse DJ
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):521-31. PubMed ID: 1545551
[TBL] [Abstract][Full Text] [Related]
15. Development of cardioplegic solution without potassium: experimental study in rat.
Reichert K; Carmo HR; Lima F; Torina AG; Vilarinho KA; Oliveira PP; Silveira Filho LM; Severino ES; Petrucci O
Rev Bras Cir Cardiovasc; 2013; 28(4):524-30. PubMed ID: 24598959
[TBL] [Abstract][Full Text] [Related]
16. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
Tachibana H
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
[TBL] [Abstract][Full Text] [Related]
17. The influence of temperature on metabolic and cellular protection of the heart during long-term ischemia: a study using P-31 magnetic resonance spectroscopy and biochemical analyses.
Bernard M; Cartoux C; Caus T; Sciaky M; Cozzone PJ
Cryobiology; 1998 Dec; 37(4):309-17. PubMed ID: 9917347
[TBL] [Abstract][Full Text] [Related]
18. Influence of the pH of cardioplegic solutions on intracellular pH, high-energy phosphates, and postarrest performance. Protective effects of acidotic, glutamate-containing cardioplegic perfusates.
Bernard M; Menasche P; Canioni P; Fontanarava E; Grousset C; Piwnica A; Cozzone P
J Thorac Cardiovasc Surg; 1985 Aug; 90(2):235-42. PubMed ID: 2410746
[TBL] [Abstract][Full Text] [Related]
19. Role of sodium pump activity in warm induction of cardioplegia combined with reperfusion of oxygenated cardioplegic solution.
Ko T; Otani H; Imamura H; Omori K; Inagaki C
J Thorac Cardiovasc Surg; 1995 Jul; 110(1):103-10. PubMed ID: 7609533
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a new cardioplegic solution for long-term heart preservation: experimental study using 31P magnetic resonance spectroscopy and biochemical analyses.
Bernard M; Caus T; Sciaky M; Monties JR; Cozzone PJ
Transplant Proc; 1996 Feb; 28(1):48-9. PubMed ID: 8644318
[No Abstract] [Full Text] [Related]
[Next] [New Search]
